<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MicroRNAs (miRNAs) from the gene cluster miR-143-145 are diminished in cells of <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> origin when compared with <z:mpath ids='MPATH_458'>normal</z:mpath> colon epithelia </plain></SENT>
<SENT sid="1" pm="."><plain>Until now, no report has addressed the coordinate action of these miRNAs in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we performed a comprehensive molecular and functional analysis of the miRNA cluster regulatory network </plain></SENT>
<SENT sid="3" pm="."><plain>First, we evaluated proliferation, migration, anchorage-independent growth and chemoresistance in the <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumor</z:e> cell lines after miR-143 and miR-145 restoration </plain></SENT>
<SENT sid="4" pm="."><plain>Then, we assessed the contribution of single genes targeted by miR-143 and miR-145 by reinforcing their expression and checking functional recovery </plain></SENT>
<SENT sid="5" pm="."><plain>Restoring miR-143 and miR-145 in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells decreases proliferation, migration and chemoresistance </plain></SENT>
<SENT sid="6" pm="."><plain>We identified cluster of differentiation 44 (CD44), Kruppel-like factor 5 (KLF5), Kirsten rat <z:hpo ids='HP_0100242'>sarcoma</z:hpo> 2 <z:mp ids='MP_0001799'>viral</z:mp> oncogene homolog (KRAS) and v-Raf murine <z:hpo ids='HP_0100242'>sarcoma</z:hpo> <z:mp ids='MP_0001799'>viral</z:mp> oncogene homolog B1 (BRAF) as proteins targeted by miR-143 and miR-145 </plain></SENT>
<SENT sid="7" pm="."><plain>Their re-expression can partially revert a decrease in transformation properties caused by the overexpression of miR-143 and miR-145 </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, we determined a set of <z:chebi fb="2" ids="33699">mRNAs</z:chebi> that are diminished after reinforcing miR-143 and miR-145 expression </plain></SENT>
<SENT sid="9" pm="."><plain>The whole transcriptome analysis ascertained that downregulated transcripts are enriched in predicted target genes in a statistically significant manner </plain></SENT>
<SENT sid="10" pm="."><plain>A number of additional genes, whose expression decreases as a direct or indirect consequence of miR-143 and miR-145, reveals a complex regulatory network that affects cell signaling pathways involved in transformation </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion, we identified a coordinated program of gene repression by miR-143 and miR-145, in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, where either of the two miRNAs share a target transcript, or where the target transcripts share a common signaling pathway </plain></SENT>
<SENT sid="12" pm="."><plain>Major mediators of the oncosuppression by miR-143 and miR-145 are genes belonging to the growth factor receptor-<z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase network and to the p53 signaling pathway.Oncogene advance online publication, 5 November 2012; doi:10.1038/onc.2012.495 </plain></SENT>
</text></document>